It is not possible to generalize whether a person with nodules can be vaccinated with the New Crown vaccine. If the nodules are caused by malignant tumors, the New Crown vaccine cannot be administered if the disease is not under effective control, but if the nodules are benign and there are no symptoms, the New Crown vaccine can be administered. The presence of nodules means that an individual has been examined and found to have abnormal nodular lesions. The etiology of nodular lesions in different parts of the body varies significantly, and can be categorized as malignant or benign according to the nature of the nodules. For patients with nodular lesions, whether or not they can be vaccinated depends on the nature of the nodules and their physical condition. Generally, malignant nodules caused by malignant tumors cannot be vaccinated with the New Crown vaccine, while benign nodules with unstable conditions are also not recommended for vaccination; however, benign nodules can be considered for vaccination when they are in stable condition and are not in any other discomfort. In conclusion, patients with nodules need to be evaluated by a medical professional to find out if an individual can be vaccinated with the New Crown vaccine. The safety and efficacy of the New Crown vaccine can only be ensured if the vaccination is not contraindicated. If you experience any discomfort after receiving the New Crown vaccine, it is recommended that you consult your physician.